Evidence map›Paper›PMID 38578541›Full record

GuidelineHepatology international2024

APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure.

Rakhi Maiwall, Satender Pal Singh, Paolo Angeli, Richard Moreau, Aleksander Krag, Virender Singh, Ashwani K Singal, S S Tan, Puneet Puri, Mamun Mahtab and 40 more

Open access · bronzeAbstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Hepatology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. [Guidelines for diagnosis and treatment of liver failure (2024 version)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Guideline
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Use of Terlipressin in Liver Transplant Candidates.Gastroenterology & hepatology · 2025
    Article
  13. Review
  14. Review
  15. [Serum testosterone and estradiol levels correlate with disease severity and prognosis in male patients with liver failure].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Article
  16. Review
  17. Article
  18. [A case of acute-on-chronic liver failure related to hepatitis B treated with tenofovir amibufenamide].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

50 authors at 20 institutions in 12 countries.

Rakhi MaiwallDepartment of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India.
Satender Pal SinghDepartment of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India.
Paolo AngeliDepartment of Internal Medicine and Hepatology, University of Padova, Padua, Italy.
Richard MoreauEuropean Foundation for the Study of Chronic Liver Failure (EF CLIF), European Association for the Study of the Liver (EASL)-CLIF Consortium, and Grifols Chair, Barcelona, Spain.
Aleksander KragDepartment of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
Virender SinghPunjab Institute of Liver and Biliary Sciences, Mohali, Punjab, India.
Ashwani K SingalDepartment of Medicine, University of Louisville School of Medicine, Trager Transplant Center and Jewish Hospital, Louisville, USA.
S S TanDepartment of Medicine, Hospital Selayang, Bata Caves, Selangor, Malaysia.
Puneet PuriDepartment of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Mamun MahtabDepartment of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
George LauHumanity and Health Medical Group, Humanity and Health Clinical Trial Center, Hong Kong SAR, China.
Qin NingDepartment and Institute of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Manoj Kumar SharmaDepartment of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India.
P N RaoDepartment of Hepatology and Nutrition, Asian Institute of Gastroenterology, Hyderabad, India.
Dharmesh KapoorDepartment of Hepatology, Gleneagles Global Hospitals, Hyderabad, Telangana, India.
Subhash GuptaDepartment of Surgery, Center for Liver and Biliary Sciences, Max Healthcare, Saket, New Delhi, India.
Ajay DusejaDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Manav WadhawanInstitute of Digestive & Liver Diseases, BLK Superspeciality Hospital Delhi, New Delhi, India.
Dinesh JothimaniInstitute of Liver Disease and Transplantation, Dr Rela Institute and Medical Centre, Bharat Institute of Higher Education and Research, Chennai, India.
Sanjiv SaigalDepartment of Gastroenterology and Hepatology, Centre for Liver and Biliary Sciences, Max Super Speciality Hospital, Saket, New Delhi, India.
Sunil TanejaDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Akash ShuklaDepartment of Gastroenterology, Seth GS Medical College and KEM Hospital, Mumbai, India.
Pankaj PuriFortis Escorts Liver & Digestive Diseases Institute, New Delhi, India.
Deepak GovilDepartment of Critical Care and Anaesthesia, Medanta-The Medicity, Gurugram, Haryana, India.
Gaurav PandeyGastroenterology and Hepatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Kaushal MadanDepartment of Gastroenterology and Hepatology, Centre for Liver and Biliary Sciences, Max Super Speciality Hospital, Saket, New Delhi, India.
C E EapenDepartment of Hepatology, Christian Medical College, Vellore, Tamil Nadu, India.
Jaya BenjaminDepartment of Clinical Nutrition, Institute of Liver and Biliary Sciences, New Delhi, India.
Ashok ChowdhuryDepartment of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India.
Shweta SinghCentre for Liver and Biliary Sciences, Max Super Speciality Hospital, Saket, New Delhi, India.
Vaishali SalaoDepartment of Critical Care, Fortis Hospital, Mulund, Mumbai, India.
Jin Mo YangDepartment of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
Saeed HamidDepartment of Hepatology, Aga Khan University, Karachi, Pakistan.
ShalimarDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Sanjiv JasujaDepartment of Nephrology, Indraprastha Apollo Hospitals, New Delhi, India.
Anand V KulkarniDeparment of Hepatology, AIG Hospitals, Hyderabad, India.
Madund A NiriellaDepartment of Medicine, Faculty of Medicine, University of Kelaniya, Colombo, Sri Lanka.
Harsh Vardhan TevethiaDepartment of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India.
Vinod AroraDepartment of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India.
R P MathurDepartment of Nephrology, Institute of Liver and Biliary Sciences, New Delhi, India.
Akash RoyDepartment of Gastroenterology, Institute of Gastrosciences and Liver Transplantation, Apollo Hospitals, Kolkata, India.
Ankur JindalDepartment of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India.
Neeraj SarafInstitute of Liver Transplantation and Regenerative Medicine, Medanta-The Medicity, Gurgaon, Delhi (NCR), India.
Nipun VermaDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Arka DeDepartment of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Narendra S ChoudharyDepartment of Hepatology and Liver Transplantation, Medanta-The Medicity Hospital, Gurugram, Haryana, India.
Rohit MehtaniDepartment of Gastroenterology, Seth GS Medical College and KEM Hospital, Mumbai, India.
Phool ChandDepartment of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India.
Omkar RudraDepartment of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India.
Shiv Kumar SarinDepartment of Hepatology, Institute of Liver and Biliary Sciences, D1 Vasant Kunj, New Delhi, 110070, India. sksarin@ilbs.in.ORCID http://orcid.org/0000-0002-0544-5610
Institute of Liver and Biliary Sciences · INMax Super Speciality Hospital · INPost Graduate Institute of Medical Education and Research · INKing Edward Memorial Hospital and Seth G.S. Medical College · INMedanta The Medicity · INVirginia Commonwealth University · USAga Khan University · PKAll India Institute of Medical Sciences · INApollo Hospitals · INAsian Institute of Gastroenterology · INBangladesh Medical University · BDBharath University · INBLK Super Speciality Hospital · INCARE Hospitals · INCatholic University of Korea · KRChinese PLA General Hospital · CNChristian Medical College, Vellore · INFortis Hospital · INGlobal Hospitals · INHospital Selayang · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute-on-chronic liver failure (ACLF) is a syndrome that is characterized by the rapid development of organ failures predisposing these patients to a high risk of short-term early death. The main causes of organ failure in these patients are bacterial infections and systemic inflammation, both of which can be severe. For the majority of these patients, a prompt liver transplant is still the only effective course of treatment. Kidneys are one of the most frequent extrahepatic organs that are affected in patients with ACLF, since acute kidney injury (AKI) is reported in 22.8-34% of patients with ACLF. Approach and management of kidney injury could improve overall outcomes in these patients. Importantly, patients with ACLF more frequently have stage 3 AKI with a low rate of response to the current treatment modalities. The objective of the present position paper is to critically review and analyze the published data on AKI in ACLF, evolve a consensus, and provide recommendations for early diagnosis, pathophysiology, prevention, and management of AKI in patients with ACLF. In the absence of direct evidence, we propose expert opinions for guidance in managing AKI in this very challenging group of patients and focus on areas of future research. This consensus will be of major importance to all hepatologists, liver transplant surgeons, and intensivists across the globe.

Indexed as

Acute Kidney InjuryAcute-On-Chronic Liver FailureHumansLiver TransplantationACLFAKIPortal hypertension

Identifiers

PMID38578541
OpenAlexW4393991019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.